|
Volumn 21, Issue 1 B, 2001, Pages 575-578
|
Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival
a
|
Author keywords
Cancer; Glucose transporter; Glut1; Immunohistochemistry; Prognosis; TCC
|
Indexed keywords
FORMALDEHYDE;
GLUCOSE TRANSPORTER;
GLUCOSE TRANSPORTER 1;
PARAFFIN;
PEROXIDASE;
POLYCLONAL ANTIBODY;
POLYCLONAL ANTIBODY MYM;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BLADDER CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER GRADING;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYSTECTOMY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
LYMPH NODE METASTASIS;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
RISK ASSESSMENT;
TRANSITIONAL CELL CARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, TRANSITIONAL CELL;
CYSTECTOMY;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOSE TRANSPORTER TYPE 1;
HUMANS;
INCIDENCE;
LIFE TABLES;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MONOSACCHARIDE TRANSPORT PROTEINS;
NEOPLASM PROTEINS;
PROGNOSIS;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0035064370
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (71)
|
References (33)
|